Abstract

Background: We assessed whether differential efficacy of early combined immunosuppression (ECI) in comparison with conventional management (CM) is present in patients with Crohn disease (CD) according to disease location.

Tags

Immunosuppression Therapy, Crohn's Disease, Drug Therapy, Early Combined Immunosuppression, Treat-to-Target, Colonic Diseases, Ileal Diseases

Read More